Massachusetts Life Sciences Center has been a great partner for the Wyss Institute #braintargetingprogram. Our first MLSC grant helped fund our platform. This 2nd grant will support brain oligo delivery and non-human primate testing. We are for MLSC's continuing support!
Last week, the #BrainTargetingProgram held its annual Sponsors and Partners Meeting. The Wyss team presented their work to collaborators, and everyone had the opportunity to take part in small group discussions and a networking reception.
Learn more: bit.ly/Brain-Targeting-Progr…
Are you a collaborative, impact-focused problem solver excited about getting drugs across the BBB? We're seeking a scientist to join our #BrainTargetingProgram to support the discovery & validation of our antibody brain shuttles. #OpenJobs#OpenRolewyss.harvard.edu/job/scienti…
We're looking for a Visiting Graduate Researcher to join the Brain Shuttle Discovery Team, part of the #BrainTargetingProgram. This position will focus on brain shuttle compound discovery and brain-targeted therapeutics discovery.
wyss.harvard.edu/job/visitin…
ALT Man standing next to a desk with a computer showing microscopy images. He is next to a sign that says, “Through my brain research, we can find a cure to neurodegenerative disease. #BrainAwarenessWeek Wyss Brain Targeting Program.”
ALT Woman sitting in a lab holding a sign that says, “Through our brain research we are crossing barriers to deliver therapeutics! #BrainAwarenessWeek”
How can we help drugs to cross the blood-brain barrier to more effectively treat neurological diseases? The Wyss' #BrainTargetingProgram is discovering and developing new, safe brain transport shuttles and effective ways to test them.
wyss.harvard.edu/news/the-wy…
Our #BrainTargetingProgram is looking for a Visiting Graduate Researcher on their Target Discovery team. You will will have one primary mentor, receive rigorous training, exposure to multiple disciplines, and gain in-depth knowledge.
wyss.harvard.edu/job/visitin…
Liqun Wang's early career in fundamental research left her wanting to help patients. Eventually, she joined the #BrainTargetingProgram to develop technologies to better deliver drugs to the brain. Learn more about Liqun and her work in this month’s #HOWysswyss.harvard.edu/news/humans…
~300 drugs have been tested for Alzheimer's disease over the last 10 years, but 99.6% have failed, in part because they couldn't reach the brain. The Wyss' #BrainTargetingProgram is developing shuttles that dramatically improve drug delivery to the brain.
wyss.harvard.edu/collaborati…
We're thrilled to welcome @EliLillyandCo as a sponsor of the #BrainTargetingProgram. They're joined by others including @Alnylam, @Visterra_Inc, & our sponsor & co-development partner @LundbeckUS. Cell Signaling Technologies, Inc & FairJourney Biologics are also partners.
ALT Group of people at Fenway Park
ALT Group of people in front of screen
ALT panorama of people sitting at tables watching presentation
Our #BrainTargetingProgram, which is developing shuttles that dramatically improve delivery of drugs to the brain, had their sponsors and partners meeting yesterday! Thank you so much to everyone who participated. bit.ly/Brain-Targeting-Progr…
ALT Large group photo in front of pull-down screen
ALT Man speaking into mic
ALT Large room of people sitting at tables watching someone present with slides on a large screen
The #BrainTargetingProgram at the Wyss is a pre-competitive, multi-partner industry collaboration that aims to identify novel transport targets and shuttle compounds to enable more effective delivery of drugs to the brain. Watch this video to learn more.
wyss.harvard.edu/media-post/…
We're seeking a Visiting Graduate Researcher for the Target Discovery area of the #BrainTargetingProgram. You will receive great mentorship,, rigorous training, and exposure to multiple disciplines. Apply today!
wyss.harvard.edu/job/visitin…